🇯🇵·1d agoIndustry
Santen Obtains Manufacturing and Marketing Approval in Japan for Rhopressa® Ophthalmic Solution 0.02%, a Treatment for Glaucoma and Ocular Hypertension
Publisher
S
Santen Pharmaceutical
Japan
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Santen Pharmaceutical
- Region
- Japan
- Scope
- Industry
- Published
- June 19, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on santen.com
Leave the platform to read the original full article on the publisher site.
Source: Santen Pharmaceutical
Scope: Industry